Press Ganey, renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem, today announced it has entered into a multi-year agreement to provide technology, counsel and additional knowledge resources to Essentia Health, an integrated healthcare system serving patients in Minnesota, Wisconsin and North Dakota. Effective July 1, Press Ganey will support Essentia Health through rapid patient experience transformation and nursing excellence across the healt

iPredictTM late AMD prediction model provides a fully automated prediction score for age-related macular degeneration (AMD), and identifies the individuals who are at risk of developing late AMD in 1 year, 2-year or 5-year. Earlier the results were published in the top scientific journals. The prediction model can potentially help prevent late AMD and save millions of people from blindness. Once high-resolution images of the patient’s eyes have been captured using a color fund

abylon Holdings Limited, one of the world’s fastest growing digital healthcare companies, today announced that it plans to accelerate its path to profitability through revenue and cost efficiencies, in response to changing market conditions. These efficiencies are being implemented during Q3 2022, with the expected financial impact being predominantly from Q4 2022 onwards. As a result, Babylon is improving its Adjusted EBITDA guidance for FY 2022 from $(295) million

Mirion Technologies, Inc. today announced the rebranding of its Medical segment as the Mirion Medical group, comprised of the organization’s healthcare-focused Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec business units. The establishment of the Mirion Medical group reinforces the Mirion commitment to leveraging its expertise in ionizing radiation for healthcare applications. “Our keystone focus on ionizing radiation has broad applicability in the healthca

Genesis HealthCare, one of the largest post-acute providers in the nation, today announced that four professionals, Mary Adams, Bonnie Zeiler, Teale Howe and Jordanne Stuart, have been chosen by the American Health Care Association and the National Center for Assisted Living (AHCA/NCAL) as national, future leaders in long-term and post-acute care. They will join AHCA/NCAL’s Future Leaders program, a year-long program that offers training and guidance for industry professionals.

Precigen, Inc.  a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company has entered into a definitive agreement for the sale of its wholly-owned non-healthcare subsidiary, Trans Ova Genetics, L.C. ("Trans Ova"), an industry-leading animal reproductive technologies company, to URUS, a holding company with cooperative and private ownership, for $170 million in upfront cash

Sanofi Global Health announces the launch of Impact®, a new brand of standard of care medicines produced by Sanofi dedicated for nonprofit distribution to at-risk populations in the world’s most impoverished countries. The Impact® brand, which includes insulin, glibenclamide and oxaliplatin amonst others, will enable the secure distribution of 30 Sanofi medicines in 40 lower-income countries. Considered essential by the World Health Organization, the medicines cover a

An opening ceremony was held at Gleneagles Hospital Hong Kong  to launch a clinical trial to evaluate the safety and immunogenicity of the omicron-specific COVID-19 inactivated vaccine as used for a booster dose healthy adults in anticipation of providing scientific evidence for future vaccination strategies. This study is led by a medical research team from the University of Hong Kong Clinical Trials Center (HKU-CTC) in collaboration with Gleneagles. A total of 300 healthy adu

Northern Utah Rehabilitation Hospital (NURH),nationally recognized as a healthcare leader for rehabilitative care for six years in a row (2015 to 2020), is proud to hold a Neuro Day event on July 7th, 2022, from 11 am to 2 pm to showcase the latest advances in neurorehabilitation. There will also be a 'Sneak Peek' event at NURH on July 6th, from 5-7 pm. The Torque3™ platform, designed to improve neurorehabilitation outcomes by enhancing neuroplasticity through their un

Isleworth Healthcare Acquisition Corporation , a special purpose acquisition company, today announced that it has entered into an agreement with Cytovia Holdings, Inc. ("Cytovia"), a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and multispecific antibodies (the "Termination Agreement") to terminate its previously announced Merger Agreement with Cytovia, which was executed in April 2022. The Termination Agreeme